Skip to main content
Watch Insiders
RAPPHealthcare

Rapport Therapeutics Inc. (RAPP) Insider Trading

In the last 90 days, 9 Rapport Therapeutics Inc. (RAPP) insiders reported 6 open-market purchases totaling $1,664,824 and 9 sales totaling $6,923,516. The most recent open-market purchase was reported on Oct 23, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$1,664,824
Corporate buyers
6
Latest transaction
Oct 23, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 23, 2026Ramiro SanchezDirectorOpen Market Purchase3,600$27.35$98,478
Oct 22, 2026Paul M SilvaDirectorOpen Market Purchase3,680$27.08$99,636
Oct 22, 2026Wendy B. YoungDirectorOpen Market Purchase3,789$26.39$99,992
Oct 22, 2026Steven M PaulDirectorOpen Market Purchase35,714$27.28$974,278
Oct 22, 2026John MaraganoreDirectorOpen Market Purchase9,411$26.45$248,891
Oct 21, 2026Abraham CeesayChief Executive OfficerSale2,210$29.16$64,448
Oct 21, 2026Troy A. IgnelziChief Financial OfficerOpen Market Purchase5,500$26.10$143,550
Oct 7, 2026Abraham CeesayChief Executive OfficerSale4,522$31.68$143,273
Sep 30, 2026Cheryl GaultChief Operating OfficerSale10,000$33.19$331,856
Sep 23, 2026Abraham CeesayChief Executive OfficerSale2,210$39.17$86,565
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

RAPP insider trading FAQ

Are RAPP insiders buying or selling?
Over the last 90 days, RAPP insiders were net sellers, reporting $1,664,824 of open-market purchases and $6,923,516 of sales.
When was the last RAPP insider purchase?
The most recent open-market purchase of Rapport Therapeutics Inc. stock by an insider was reported on Oct 23, 2026, one of 6 purchases in the last 90 days.
Where does RAPP insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Rapport Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.